Joilton Lutterbach admitted to taking performance-enhancing drugs prior to getting a short notice opportunity with the UFC, and now, he is dealing with the repercussions.
On Tuesday, Combat Sports Anti-Doping (CSAD) announced that Lutterbach accepted a 24-month sanction for violating the UFC’s anti-doping policy. The test was administered June 8, two weeks before Lutterbach was set to face Shara Magomedov at UFC Saudi Arabia.
Lutterbach tested positive “for the presence of 3a-Hydroxy-2a-methyl-5a-androstan-17-one, a metabolite of drostanolone,” which is an anabolic steroid. The 31-year-old was made aware of the positive test on June 20 while at the host hotel two days before the event. According to the release, he admitted to “extensive use” of the prohibited substance prior to his signing, and because he didn’t declare the use ahead of time, Lutterbach received the stronger penalty.
Additionally, Lutterbach’s UFC contract was terminated based on the failed test, and Lutterbach admitting to it — which he also did on social media after he was pulled from the card.
“I actually used juice three months ago and had no idea that I would sign with the UFC,” Lutterbach wrote at the time. “I could have hidden in the mountains or gone to Thailand to hide as many do and are not tested, but I preferred to take the risk and believe I was clean and fit to fight.”
Lutterbach will be eligible to return on June 23, 2026.
